AGP Executive Report
Last update: 11 hours agoQuake Response: After a 7.0-magnitude earthquake in Xizang killed 16 people and injured 76, medical teams treated residents at mobile stations while disease-control teams monitored more than 3,600 people at resettlement sites and checked water safety. Cancer Care: At ESMO 2026, a China-led phase III trial found ivonescimab plus chemotherapy cut the risk of death by 25% versus durvalumab plus chemotherapy for advanced biliary tract cancer. Another trial found sacituzumab tirumotecan plus pembrolizumab extended median progression-free survival to 15 months, from 5.7 months, in first-line treatment of PD-L1-negative lung cancer. Heart Health: A study of nearly 486,000 adults in China linked regular tea drinking with an 11% lower risk of vascular disease over about nine years; the findings show an association, not proof that tea prevents disease. Hepatitis Testing: A multicenter evaluation at three Chinese hospitals found a combined hepatitis C antibody-and-antigen test closely matched a two-test workflow, though RNA testing remains important to confirm active infection.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
